4176 - 4200 of 9034 Results
Title
Year
-
OPENTitle: GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease SusceptibilityJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 3Start Page: 761End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.70127Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70127Citation Count: 0
-
OPENTitle: Insights from a cross-sectional population-based study of 10,929 Australians living with Parkinson's disease: risk factors, comorbidities, and sex differencesJournal Name: The Lancet Regional Health - Western PacificPublisher: Elsevier BVVol: 68Issue #:Start Page: 101816End Page: 101816Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.lanwpc.2026.101816Best OA location URL: https://doi.org/10.1016/j.lanwpc.2026.101816Citation Count: 1
-
OPENTitle: Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser129 in Biological SamplesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 7Start Page: 1238End Page: 1248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00676Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00676Citation Count: 30
- Transplant and risk of Parkinson disease2019RESTRICTEDTitle: Transplant and risk of Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 149End Page: 155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.013Citation Count: 8
- Exploring the neuroprotective potential of immunosuppressants in Parkinson's disease2025RESTRICTEDTitle: Exploring the neuroprotective potential of immunosuppressants in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 132Issue #:Start Page: 107294End Page: 107294Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107294Citation Count: 2
-
OPENTitle: Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patientsJournal Name: Toxicology ReportsPublisher: Elsevier BVVol: 4Issue #:Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.toxrep.2017.03.005Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S221475001730015X-fx1_lrg.jpgCitation Count: 29
-
OPENTitle: Network spreading and local biological vulnerability in amyotrophic lateral sclerosisJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 1153End Page: 1153Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-025-08561-3Best OA location URL: https://www.nature.com/articles/s42003-025-08561-3.pdfCitation Count: 4
- The impact of non-motor symptoms on physical activity in Parkinson’s disease2025OPENTitle: The impact of non-motor symptoms on physical activity in Parkinson’s diseaseJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/17582024.2025.2607694Citation Count: 1
- NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis2024OPENTitle: NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body MyositisJournal Name: Journal of Cachexia, Sarcopenia and MusclePublisher: WileyVol: 16Issue #: 1Start Page: e13672End Page: e13672Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/jcsm.13672Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcsm.13672Citation Count: 14
-
RESTRICTEDTitle: MitoNEET (CISD1) Knockout Mice Show Signs of Striatal Mitochondrial Dysfunction and a Parkinson’s Disease PhenotypeJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 8Issue #: 12Start Page: 2759End Page: 2765Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00287Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5964979Citation Count: 95
-
OPENTitle: (Patho‐)physiological relevance of PINK 1‐dependent ubiquitin phosphorylationJournal Name: The EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 9Start Page: 1114End Page: 1130Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embr.201540514Best OA location URL: http://doi.org/10.15252/embr.201540514Citation Count: 185
- Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers2013RESTRICTEDTitle: Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriersJournal Name: CortexPublisher: Elsevier BVVol: 49Issue #: 9Start Page: 2501End Page: 2511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2012.12.017Citation Count: 45
- Reply to letter to the editor “Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges”2019RESTRICTEDTitle: Reply to letter to the editor “Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges”Journal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 5Start Page: 1330End Page: 1331Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.06.014Citation Count: 0
- Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy2018RESTRICTEDTitle: Abnormalities on structural MRI associate with faster disease progression in multiple system atrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 58Issue #:Start Page: 23End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.004Citation Count: 23
-
OPENTitle: Quantitative Proteomics of Presynaptic Mitochondria Reveal an Overexpression and Biological Relevance of Neuronal MitoNEET in Postnatal Brain DevelopmentJournal Name: Developmental NeurobiologyPublisher: WileyVol: 79Issue #: 4Start Page: 370End Page: 386Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/dneu.22684Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6543812Citation Count: 16
-
OPENTitle: Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteomeJournal Name: PROTEOMICSPublisher: WileyVol: 15Issue #: 2-3Start Page: 500End Page: 507Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201400171Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4598062Citation Count: 67
-
OPENTitle: Alpha-synuclein is increased in erythrocytes in parkinson’s disease casesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 31837End Page: 31837Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-025-11979-8Best OA location URL: https://www.nature.com/articles/s41598-025-11979-8.pdfCitation Count: 2
- Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriers2016RESTRICTEDTitle: Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriersJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 6Start Page: 889End Page: 897Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26529Citation Count: 95
- Placebo Effects in the Treatment of Depression—Implications for the Psychedelic Renaissance2025RESTRICTEDTitle: Placebo Effects in the Treatment of Depression—Implications for the Psychedelic RenaissanceJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 44Issue #: 1Start Page: 63End Page: 75Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2025.08.009Citation Count: 1
-
OPENTitle: Network Models of Neurodegeneration: Bridging Neuronal Dynamics and Disease ProgressionJournal Name: IEEE Reviews in Biomedical EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 19Issue #:Start Page: 140End Page: 158Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/rbme.2025.3643310Best OA location URL: https://doi.org/10.1109/rbme.2025.3643310Citation Count: 3
-
OPENTitle: Substantia nigra hyperechogenicity with LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 5Start Page: 885End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23644Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3082617Citation Count: 37
-
OPENTitle: Heat Shock Protein 70 as a Sex-Skewed Regulator of α-SynucleinopathyJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 4Start Page: 2541End Page: 2564Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-021-01114-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01114-6.pdfCitation Count: 10
-
OPENTitle: Tremor in Spinocerebellar Ataxia Type 12Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 1Start Page: 76End Page: 78Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12015Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12015Citation Count: 12
-
OPENTitle: A History of Senile Plaques: From Alzheimer to Amyloid ImagingJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 81Issue #: 6Start Page: 387End Page: 413Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlac030Best OA location URL: https://academic.oup.com/jnen/article-pdf/81/6/387/43778548/nlac030.pdfCitation Count: 32
-
OPENTitle: Classification of Parkinson’s disease and isolated REM sleep behaviour disorder: delineating progression markers from the sebum volatilomeJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 202End Page: 202Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01026-8Best OA location URL: https://www.nature.com/articles/s41531-025-01026-8.pdfCitation Count: 3
